eXo Imaging, Inc.
Funding rounds
5 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2025 | $44 M | No. 5 | $10 to $50 million | equity, options | SEC | |
| Apr 2020 | $51 M | No. 4 | $50 to $250 million | equity, options | SEC | |
| May 2019 | $32 M | No. 3 | $10 to $50 million | equity | SEC | |
| Oct 2017 | $7 M | No. 2 | $2 to $10 million | equity | SEC | |
| Jan 2017 | $6 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
eXo Imaging, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2025).
SEC Form D · Jun 2025
The industry group it chose in its notices: Other Health Care.
SEC Form D · Jun 2025
That is all the official record says: eXo Imaging, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
8 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| BlackRock Health Sciences Term Trust | Fund or asset manager | $1 Mheld | not stated | Holds shares (fund report, Jun 2026) | SEC Form N-PORT |
| BlackRock Strategic Income Opportunities Portfolio | Fund or asset manager | $0 Mheld | not stated | Holds Series D shares (fund report, Jun 2026) | SEC Form N-PORT |
| BlackRock Global Allocation Fund, Inc. | Fund or asset manager | $0 Mheld | not stated | Holds Series D shares (fund report, Jul 2026) | SEC Form N-PORT |
| BlackRock Global Allocation V.I. Fund | Fund or asset manager | $0 Mheld | not stated | Holds Series D shares (fund report, Jun 2026) | SEC Form N-PORT |
| BlackRock Capital Allocation Term Trust | Fund or asset manager | $0 Mheld | not stated | Holds shares (fund report, Jun 2026) | SEC Form N-PORT |
| BlackRock Health Sciences Trust | Fund or asset manager | $0 Mheld | not stated | Holds shares (fund report, Jun 2026) | SEC Form N-PORT |
| BlackRock Health Sciences Opportunities Portfolio | Fund or asset manager | $0 Mheld | not stated | Holds shares (fund report, May 2026) | SEC Form N-PORT |
| BlackRock Global Allocation Portfolio | Fund or asset manager | not stated | not stated | Holds Series D shares (fund report, Jun 2026) | SEC Form N-PORT |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 87 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Joe Adam | Executive officer | Jun 2025 |
| Lori Munoz | Executive officer | Jun 2025 |
| Pushkar Singh | Executive officer | Jun 2025 |
| Sandeep Akkaraju | Executive officer | Jun 2025 |
| Simon Prakash | Executive officer | Jun 2025 |
| Yusuf Haque, Ph.D. | Executive officer | Jun 2025 |
| Barbara Bryzek | Executive officer | Nov 2020 |
| Janusz Bryzek | Executive officer | Nov 2020 |
| Neal Bhadkamkar | Director | Jun 2025 |
| Omar Ishrak | Director | Jun 2025 |
| Parker Cassidy | Director | Jun 2025 |
| Sandeep Akkaraju | Director | Jun 2025 |
| Suzanne Foster | Director | Jun 2025 |
| Eric King | Director | Nov 2020 |
| Janusz Bryzek | Director | Nov 2020 |
| Ted Koutouzis | Director | Nov 2020 |
| Mirsaid Seyed-Boloforos | Director | Apr 2020 |
| Mohammad El-Bibany | Director | Oct 2017 |